Zacks Research Issues Optimistic Outlook for THC Earnings

Tenet Healthcare Co. (NYSE:THC - Free Report) - Research analysts at Zacks Research boosted their Q1 2025 EPS estimates for Tenet Healthcare in a note issued to investors on Wednesday, February 26th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $3.05 for the quarter, up from their previous forecast of $2.94. The consensus estimate for Tenet Healthcare's current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare's Q3 2025 earnings at $2.75 EPS, Q2 2026 earnings at $3.34 EPS, Q3 2026 earnings at $3.09 EPS, Q4 2026 earnings at $3.57 EPS, Q4 2026 earnings at $3.57 EPS and FY2027 earnings at $15.92 EPS.

Other research analysts also recently issued research reports about the stock. KeyCorp decreased their price objective on shares of Tenet Healthcare from $200.00 to $185.00 and set an "overweight" rating for the company in a research report on Tuesday, January 7th. Wells Fargo & Company downgraded Tenet Healthcare from an "overweight" rating to an "equal weight" rating and lowered their price target for the stock from $205.00 to $150.00 in a research report on Monday, November 25th. StockNews.com upgraded Tenet Healthcare from a "hold" rating to a "buy" rating in a research report on Tuesday, February 25th. Barclays decreased their target price on Tenet Healthcare from $190.00 to $161.00 and set an "overweight" rating on the stock in a research report on Thursday, February 13th. Finally, JPMorgan Chase & Co. reissued an "overweight" rating and issued a $175.00 price target on shares of Tenet Healthcare in a report on Tuesday, December 17th. Three equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $163.88.

Tenet Healthcare Stock Performance

Shares of NYSE:THC traded down $2.11 during trading on Friday, hitting $124.48. 1,645,556 shares of the stock traded hands, compared to its average volume of 1,419,371. The company has a fifty day moving average price of $132.92 and a two-hundred day moving average price of $146.77. Tenet Healthcare has a 52-week low of $90.03 and a 52-week high of $171.20. The company has a market cap of $11.84 billion, a price-to-earnings ratio of 3.86, a P/E/G ratio of 1.02 and a beta of 2.05. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25.

Tenet Healthcare (NYSE:THC - Get Free Report) last issued its earnings results on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, topping analysts' consensus estimates of $2.95 by $0.49. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%.

Hedge Funds Weigh In On Tenet Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. New Wave Wealth Advisors LLC purchased a new position in shares of Tenet Healthcare during the 4th quarter worth $343,000. Swedbank AB raised its stake in Tenet Healthcare by 100.0% during the fourth quarter. Swedbank AB now owns 40,000 shares of the company's stock worth $5,049,000 after purchasing an additional 20,000 shares during the period. Signet Financial Management LLC purchased a new stake in shares of Tenet Healthcare in the 4th quarter valued at approximately $1,526,000. China Universal Asset Management Co. Ltd. acquired a new stake in shares of Tenet Healthcare during the 4th quarter worth approximately $410,000. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in Tenet Healthcare in the fourth quarter valued at approximately $5,892,000. Institutional investors and hedge funds own 95.44% of the company's stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.